Authors


Michael Sherman, MD

Latest:

Cost Burden of Hepatitis C Virus Treatment in Commercially Insured Patients

Rates of hepatitis C virus (HCV) treatment in a commercially insured population doubled after availability of new direct-acting antivirals. Member out-of-pocket spending was kept low while the health plan bore 99% of spending on HCV medications.


Glenda Frederick, BA

Latest:

Medication Burden in Patients With Acute Coronary Syndromes

Patients endure heavy medication complexity following hospital discharge for acute coronary syndrome.


Danielle L. Kruger, BA

Latest:

Hepatitis C Care Cascade Among Persons Born 1945-1965: 3 Medical Centers

In this analysis of patients with newly diagnosed hepatitis C, linkage to care was largely successful in the 1945-1965 birth cohort, but treatment initiation remained low. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.


M. Kristina Wharton, MPA, MPH

Latest:

Ensuring Access to Prescription Medications in the Post-ACA Healthcare Access Landscape: The Essential Role of FQHCs in the Safety Net for the Underinsured

The role of federally qualified health centers is evaluated in serving uninsured patients and providing need-based, reduced-cost prescription medications in the post–Affordable Care Act landscape.








Joseph S. Ross, MD

Latest:

Adoption of New Agents and Changes in Treatment Patterns for Hepatitis C: 2010-2014

New hepatitis C medications have been quickly adopted into practice and increased treatment rate. The median out-of-pocket costs of new medications were relatively low.


Candace T. Peterson, PhD

Latest:

A Team Approach to Systematic Behavioral Screening and Intervention

Expanding primary care teams with trained and supported paraprofessionals enables systematic delivery of widely recommended, evidence-based, cost-saving alcohol, drug, and depression screening and intervention services.




Patricia Fontaine, MD, MS

Latest:

Patient-Centered Medical Home Cost Reductions Limited to Complex Patients

From 2005 to 2009, improved clinical practice systems were associated with cost reductions only for medically complex patients.



Jennifer S. Myers, MD

Latest:

Chasing High Performance: Best Business Practices for Using Health Information Technology to Advance Patient Safety

This commentary reflects how high-performing healthcare organizations use health information technology to advance patient safety.



Anish S. Patel, BS

Latest:

Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.



J. Erin Bagalman, MSW

Latest:

Cost Burden of Treatment Resistance in Patients With Depression

When a clinical staging algorithm for treatment-resistant depression was applied to administrative claims data, higher scores predicted higher future medical costs.


Connie S. Uratsu

Latest:

The Effectiveness of Diabetes Care Management in Managed Care

Care management patients experienced slightly greater improvements in CVD risk factor control than a set of matched controls. Both populations showed significant improvement over time.


Yang Liu, MD

Latest:

Evaluating a Hepatitis C Quality Gap: Missed Opportunities for HCV-Related Care

Management of hepatitis C screening results can be optimized to ensure that patients receive high-quality care, reducing morbidity and costs related to the virus.






Stuart E. Siegel, MD

Latest:

Bridging the Care Gap Between Pediatric and Young Adult Cancer

Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.


Jianwei Leng, MStat

Latest:

VA Geriatric Scholars Program’s Impact on Prescribing Potentially Inappropriate Medications

Primary care teams reduced their prescribing of potentially inappropriate medications to older veterans after participation in the Veterans Affairs (VA) Geriatric Scholars Program.


Christine Rodriguez, MPH

Latest:

Accessing the Cure: Helping Patients With Hepatitis C Overcome Barriers to Care

This case study from the National Viral Hepatitis Roundtable and Project Inform describes the cost-sharing mechanisms that create significant barriers to accessing new hepatitis C treatments, which require a strong advocate response to improve patient access.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo